PIH49 Variation In The Use Of Inhaled Respiratory Medications For Preterm Infants With Bronchopulmonary Dysplasia  by Slaughter, J.L. et al.
A78 V A L U E  I N  H E A L T H  1 6  ( 2 0 1 3 )  A 1 - A 2 9 8  
  
 
exposed users were similar to results for all users. CONCLUSIONS: Inappropriate 
prescribing in the elderly contributes to negative clinical and economic 
outcomes. Specific interventions have been utilized to decrease incidence of 
inappropriate prescribing, but there is little evidence on the long-term 
sustainability of such project effects. The significant reductions in PIM exposure 
after our intervention appear to have continued after its discontinuation, 
supporting the idea that the intervention concretely impacted GPs’ prescribing 
behavior. Patient and GP characteristics did not contribute to the effect of the 
intervention.  
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OBJECTIVES: During the 1990s, U.S. outpatient antibiotic utilization declined 
after the launch of national educational campaigns; however, it is unknown if 
these trends were sustained in the last decade. The purpose of this study was to 
describe U.S. antibiotic prescribing trends from 2000 to 2010. METHODS: This 
was a retrospective analysis of nationally representative data from the Medical 
Expenditure Panel Survey (MEPS) from 2000 to 2010. Trends in population-based 
prescribing were examined for overall antibiotics and for non-otitis media (non-
OM) respiratory tract infections (RTIs) [bronchitis, pharyngitis, sinusitis, and 
upper-RTIs as defined by ICD-9-CM codes 460-463, 465, 466, 473, and 490]. Rates 
were reported for three age groups: children and adolescents (younger than 18 
years), adults (18-64 years), and older adults (≥65 years). Antibiotic prescriptions 
were identified using the Lexicon Multum classification system. Population 
estimates were obtained from the U.S. Census Bureau, and annual rates were 
reported per 1,000 persons. RESULTS: The overall annual rate of antibiotic 
prescriptions decreased from 377 per 1000 persons in 2000 to 365 per 1,000 
persons in 2010. Among children and adolescents, the overall and non-OM RTI 
antibiotic prescribing rates decreased by 19% and 12%, respectively. Both rates 
remained stable in adults. In contrast, the overall and non-OM RTI antibiotic 
prescribing rates increased by 16% and 7%, respectively, in older adults. This 
increase was attributed to a 30% increase in the use of fluoroquinolones and 
second-generation macrolides over the study period. CONCLUSIONS: Overall, 
antibiotic prescribing has decreased in the U.S. population over the last decade. 
This decrease has mostly occurred in children and adolescents while older 
adults have actually experienced an increase in antibiotic prescribing. Focused 
public policy initiatives are needed to promote the judicious use of antibiotics in 
older adults.  
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OBJECTIVES: The relationship between inequities in socioeconomic factors (i.e. 
poverty) and adverse health outcomes has being studied before, but most studies 
were aggregated by country. A further disaggregation may contribute to causality 
and may help explain the within country differences and lack of improvements 
of some health indexes. In order to assess inequalities in Colombia this study 
evaluate by geographical region (state) of the infant mortality rate in Colombia in 
1993 and 2005, the two years where the census took place. METHODS: This 
ecological study measures regional inequalities in the infant mortality rate (IMR), 
using these indexes: Rate difference (RD), incidence rate ratio (IRR) and 
population attributable risk (PAR). Poverty was measured as the index of 
unsatisfied needs (Necesidades Básicas Insatisfechas, NBI). A linear regression 
was made for the association between IMR and NBI (poverty), and beta-
coefficients with 95% confidence intervals (95%CI) were estimated. RESULTS: In 
1993, the absolute difference between regions (states) with more and less poverty 
(Chocó: 80.4%; Bogotá, D.C.:17.3%) was 63.1%. In 2005, this difference was 70.4%. 
For these years, the IRR of IMR between those (Choco and Bogota) states was 2.9 
y 4.2 and RD 56.4 y 59.2, respectively. The R-square between poverty and IMR 
was in 2005 63.8%, versus a R-square of 34.2% for 1993. The beta-coefficient of 
linear regression was 0.339 for 1993 (IC 95%, 0.167-0.552). For each perceptual 
point that decreases poverty in the states, a reduction of TMI by 0.339 for each 
1,000 live births. In 2005, this reduction was 0.646 for each 1,000 live births (IC 
95%, 0.468-0.823). CONCLUSIONS: Although Colombia has a trend of TMI 
reduction, health inequalities persist between states in the country. These 
inequalities increased between 1993 and 2005.  
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OBJECTIVES: An aging population translates into an increase in drug use, while 
medication management is challenged by the uniqueness of geriatric 
pharmacology. Our objective is to understand the most frequent IMUs dispensed 
from community pharmacies. METHODS: We used Beers’ 2002 Criteria 
(regardless of diagnoses and conditions) in our analysis. The prescription 
repository from a downtown community pharmacy (Yalova, Turkey) with  
a diverse socio-economic demographic profile was retrospectively monitored to 
identify IMU. The Social Security Institution (SGK)’s “Medula” database  
was utilized to identify patients to whom at least one prescription was dispensed 
in the month of October 2011. The patient records were tracked back to  
the period between September and November 2011 to analyze their prescriptions 
details. SGK-Medula prescriptions for 192 elderly patients (≥60 years-old)  
were identified (108 female and 84 male). RESULTS: From data analysis, 424 
cases of IMU were identified. Each patient was exposed on average to 2.2 IMUs. 
The majority (61.8%) of all IMU cases involved non steroidal anti-inflammatory 
drugs (NSAID). The average use of NSAID per patient was 1.36. There was  
no statistically significant difference between female and male NSAID IMU.  
The second most IMU was chlorpheniramine usage, with 9% of all IMU  
cases; again no statistically significant difference was found between females 
and males. The third most frequently observed IMU involved nitrofurantoin  
in males (13.1%), and hydroxyzine in females (10.2%). Regardless of gender, 
ferrous sulphate (4.0%) was ranked the third overall most recorded  
IMU. Stimulant laxatives, alprazolam, doxazosin, and ticlopidine were also 
among the frequently observed IMU cases in this study. CONCLUSIONS: 
Prescriptions for the elderly should be systematically evaluated to check for  
IMU. NSAIDs, chlorpheniramine, nitrofurantoin, hydroxyzine, and ferrous 
sulphate may be especially worrisome due to high prevalence of exposure to 
these agents.  
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OBJECTIVES: Seasonal flu vaccine uptake rates among socioeconomically 
disadvantaged children have been documented, but not much is known about 
the relationship between doctor’s recommendation for seasonal and H1N1 flu 
vaccines. During the 2009-2010 flu season, persons had access to two separate 
influenza vaccines to prevent H1N1- and seasonal flu-related complications. The 
study explored the impact of doctor’s recommendations for seasonal and H1N1 
flu vaccines on Medicaid/State Children’s Health Insurance Program (SCHIP)-
covered children’s seasonal and H1N1 flu vaccination. The hypothesis to be 
tested was that a doctor’s recommendation increases vaccine uptake for both 
vaccines. The current study addressed different marginal effects estimates from 
the bivariate model identification to characterize this hypothesis. METHODS: 
This study used the Centers for Disease Control and Prevention National 2009 
H1N1 Flu Survey and focused on the nationally representative subsample of 1794 
Medicaid/SCHIP children between the ages of 6 months to 17 years old.  
A bivariate probit model was used to jointly estimate the effects of doctors’ 
recommendations on seasonal and H1N1 flu vaccination. The model controlled 
for age, race, gender, household income, census region, number of household 
children, and past sickness. RESULTS: The choice framework resulted in  
a significant estimation of rho=0.532 (p=0.000) suggesting a positive correlation 
between the outcomes of seasonal and H1N1 vaccination. The average marginal 
effect from the bivariate probit model estimated that Medicaid/SCHIP children 
receiving a doctor’s recommendation for both, seasonal, and H1N1 were 34.5% 
(p=0.000), 11.5% (p=0.000), 14.1% (p=0.000), respectively, more likely to acquire 
seasonal and H1N1 flu vaccinations versus a doctor’s recommendation  
for neither. CONCLUSIONS: The results suggest a doctor’s recommendation  
was influential for vaccine uptake for Medicaid/SCHIP covered children during 
the 2009-2010 flu season. The findings suggest doctor’s recommendation  
should be an important factor in policy efforts to address barriers to flu 
vaccination.  
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OBJECTIVES: To determine 1) between-hospital variation in bronchodilator (BD) 
and inhaled corticosteroid (ICS) use for preterm infants with bronchopulmonary 
dysplasia (BPD) including hospital-specific treatment frequency, and 2) 
demographic and clinical variables associated with diuretic administration. 
METHODS: A retrospective cohort investigation was conducted using the 
Pediatric Health Information System (PHIS) database to determine between-
hospital variation in BD (Beta2-agonists; ipratroprium) and ICS utilization, as 
well as variables associated with their administration, among infants with 
evolving BPD at 28 days of age, born at 35 U.S. children's hospitals between 
January 2007-June 2011. Inclusion criteria: <29 weeks gestation, <1.5 kgs 
birthweight, survived 28 days, and on oxygen, CPAP, and/or ventilation for ≥28 
consecutive days. Between-hospital percent-use comparisons were limited to 
hospitals with >25 included infants to prevent overweighting of smaller-samples. 
RESULTS: During the 54-month study period, 1429 infants were identified with 
evolving BPD, of which 544 (38%) received bronchodilators (BDs) and 352 (25%) 
received ICS. Hospitals differed significantly in the use of BDs [intraclass 
correlation coefficient (ICC): 0.35] and ICS (ICC: 0.42) even after controlling for 
observed confounders with multilevel, multivariable logistic regression. By 
hospital (N=15), the percentage of patients that ever received these medications 
ranged from 5-81% (median:33; IQR:8%-56%) for BDs and from 0-60% (12; 2-35%) 
for ICS. At 3 hospitals (20%) no patients received ICS. Risk factors significantly 
associated with bronchodilator administration included: increasing length of 
mechanical ventilation, birth weight 500-749 grams (reference group: 1000-1499 
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grams), and male gender. Increasing length of mechanical ventilation and birth 
weight 500-999 grams were associated with ever receiving inhaled 
corticosteroids. CONCLUSIONS: Bronchodilator and ICS use are common for 
infants with BPD at U.S. Children's hospitals, although frequency of use varies 
significantly. The effectiveness and safety of their use in these infants needs to 
be determined, in order to develop evidence-based recommendations.  
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OBJECTIVES: Research has shown that employees caring for older adults may 
experience physiological and psychosocial effects and require family supports 
that may vary across different ethnic groups. The purpose of this study was to 
explore differences in caregiving skills; caregiver burden; self-efficacy; and 
quality of life, health and well-being of African-American and Caucasian 
caregivers who are providing care for an older adult. METHODS: A total of 153 
Caucasian and African-American adults currently working and caring for an 
older adult were personally interviewed. RESULTS: The typical working caregiver 
was a 49-year-old woman caring for her 79-year-old mother with African-
American caregivers more likely to be living in the same household. In the past 
six months, African-American caregivers were more likely to have taken off 
work more than twenty hours and used the telephone at work one to five times a 
week for caregiving responsibilities. Caregiver Self Efficacy was positively related 
to Caregiver Rewards (r=.424, p<0.001) and negatively related to Burden (r=-0.310, 
p<0.001) for both groups. Regarding Caregiving Skills, African-American 
caregivers rated their skills in communicating with their older loved one more 
highly than Caucasian (beta=.332, p<0.001) and were more likely to have taken 
more than 20 hours off work (beta =0.201, p<0.05). African-American caregivers 
were less confident of finding information and good resources for their elder 
care recipient and themselves than Caucasian caregivers (beta = -0.175, p<0.05 
and beta = -0.183, p<0.05 respectively). Those caregivers with greater self-efficacy 
and greater caregiver rewards reported greater quality of life. There were 
significant differences in caregiver burden with African-Americans feeling a 
greater level of burden. CONCLUSIONS: The differing effects of elder caregiving 
among African-Americans and Caucasian caregivers may require different, more 
personalized caregiver interventions and supports to reduce the caregiver 
burden, increase feelings of rewards, and improve the quality of life for both 
ethnic groups.  
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OBJECTIVES: This study estimates lipid profile changes and abnormalities in 
treatment naïve HIV patients initiating atazanavir/ritonavir (ATV/r) versus 
darunavir/ritonavir (DRV/r) using a matched indirect comparison. METHODS: 
Two similarly designed randomized trials were identified. Individual patient-
level data were available for the CASTLE trial comparing ATV/r (n=430) and 
lopinavir/r (LPV/r) (n=438); published summary data were used from the 
ARTEMIS trial comparing DRV/r (n=343) and LPV/r (n=346). To adjust for cross-
trial differences, CASTLE patients were re-weighted to match summary baseline 
characteristics in ARTEMIS. Lipid profile changes and serious (grade 2-4) lipid 
laboratory abnormalities (LA) at 48 weeks were compared between balanced trial 
populations after matching. If significant differences in LPV/r outcomes existed 
after matching, the differences between active treatments and LPV/r were 
compared across trials. RESULTS: Data from all patients in the two trials were 
included. Before matching, CASTLE patients at baseline had a higher proportion 
of HIV-1 RNA>100,000 copies/mL, a lower proportion CDC class C, and lower 
median CD4 cell count than ARTEMIS patients. An unadjusted cross-trial 
comparison at 48 weeks showed that ATV/r and DRV/r had similar changes in 
total cholesterol, low density lipoprotein (LDL), and triglycerides, but ATV/r had 
significantly lower rates of total cholesterol LA (7% vs.13%, p=0.008) and LDL LA 
(8% vs. 13%, p=0.040). After balancing mean baseline characteristics, ATV/r and 
DRV/r at 48 weeks had similar changes in total cholesterol, LDL, and triglycerides 
(adjusted difference [AD]= -7.19, -7.11 and 7.59 mg/dL, respectively) and similar 
percentages of grade 2-4 triglycerides and cholesterol LAs (AD=0% and 1%, 
respectively); however, ATV/r had a significantly lower rate of serious LDL LA 
(AD=-9%, p=0.006). CONCLUSIONS: While the overall lipid profiles of ATV/r and 
DRV/r were similar at 48 weeks in this matching-adjusted indirect comparison, 
ATV/r had a significantly lower rate of serious LDL LA.  
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OBJECTIVES: Clostridium difficile infection (CDI) primarily occurs in elderly 
adults and contributes to excess patient mortality, readmissions, hospital costs, 
and post-discharge costs. Two-thirds of CDI hospitalizations are for patients 
with CDI as a secondary diagnosis (“secondary CDI”). This study assesses the 
burden of illness of secondary CDI on outcomes and healthcare utilization for 
hospitalized Medicare beneficiaries. METHODS: Using a 5% random sample of 
Medicare claims from 2009–2010, patients with and without secondary CDI and 
no prior hospitalization within the previous 30 days were identified. Prior year 
claims data were used to describe case mix and baseline characteristics. 
Propensity scores were developed to match CDI and non-CDI patients on 
potential confounding factors. Outcomes of interest were: index episode length-
of-stay (LOS), emergency department (ED) and ICU use, inpatient mortality, post-
discharge mortality, readmissions, and acute care use. RESULTS: The final 
sample size after a propensity score match was 3262 patients in each patient 
cohort. Secondary CDI was associated with an 80% increase in hospital LOS, and 
a greater than 160% increase in ICU days, relative to patients without CDI. 
Secondary CDI was associated with an 80% increase in both inpatient and 30-day 
post-discharge mortality. Inpatient mortality for immunocompromized patients 
was 130% greater than like patients without CDI. Secondary CDI was associated 
with a 41% increase in 30-day CDI readmission rates and a 46% increase in the 
number of readmissions per admission. Immunocompromised patients with 
secondary CDI were associated with a 180% increase in post-discharge CDI-
related ED visits and a 65% increase in post-discharge skilled nursing facility 
admissions. CONCLUSIONS: Secondary CDI in hospitalized Medicare 
beneficiaries is associated with considerable negative impacts on LOS, mortality, 
readmission rates, and post-discharge utilization compared to matched controls. 
Consequently, comprehensive CDI prevention and treatment strategies are 
needed to decrease resource utilization and burden in patients who develop 
secondary CDI.  
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OBJECTIVES: Billing and claims data can potentially be used to identify surgical 
site infections (SSIs) for quality improvement initiatives. We investigated the 
effect that variation in procedure coding by providers and facilities has on the 
calculated SSI incidence. METHODS: We established a retrospective cohort study 
of individuals aged 6 months – 64 years with ICD-9-CM procedure or CPT-4® 
codes from facility and/or provider claims for umbilical, femoral/inguinal, or 
incisional/ventral herniorrhaphy from 1/1/2004-12/31/2010 using private insurer 
claims data. SSIs within 90 days were identified by ICD-9-CM diagnosis codes, 
with censoring for other surgeries within 90 days. Complex surgeries with 
additional procedures performed on or before the herniorrhaphy date during a 
hospitalization were excluded. RESULTS: 155,748 non-complex herniorrhaphy 
procedures were initially identified based on distinct procedure dates >7 days 
apart. The number of distinct procedures was reduced to 144,220 after removing 
procedures with no supportive evidence for operation (e.g., anesthesia, operating 
room revenue codes, pathology; n=4,609) and surgeries coded for >1 hernia site 
or unclassified (n=6,919). The percentage of procedures complicated by SSI was 
compared according to the stringency of identification of hernia site. Using all 
claims coded for herniorrhaphy (facility and/or provider), 1.23% (363/29,582) of 
umbilical, 0.48% (433/90,231) of femoral/inguinal, and 4.00% (976/24,407) of 
incisional/ventral procedures were complicated by SSI within 90 days. In 
contrast, the percentages of procedures complicated by SSI were 1.17% 
(297/25,323) for umbilical, 0.46% (367/79,063) for femoral/inguinal, and 4.18% 
(752/17,981) for incisional/ventral herniorrhaphy when agreement between the 
provider and facility procedure coding was required to define the hernia site. 
CONCLUSIONS: Use of claims data to determine SSI rates requires careful 
classification of procedures, particularly when characteristics of the surgical 
procedure are important risk factors for infection.  
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OBJECTIVES: Multiple sclerosis (MS) is characterized by autoimmune mediated 
demyelination of the central nervous system, and affects nearly 300,000 
individuals in the United States (US). Immunosuppressive MS therapy often 
leads to infections, which in turn may cause relapse or exacerbation of MS 
symptoms. This study is the first to evaluate the magnitude of the association 
between MS and serious infections in a US population. METHODS: Adult patients 
with MS, within the US Veterans Health Administration (VHA) system from 1999-
2010 were identified. Those without encounters 6 months or more before the 
first diagnosis were excluded. Each MS patient was matched, on age and sex, 
with up to 4 non-MS patients. Cox Proportional Hazards regression models were 
developed to assess the influence of MS on serious infections identified by ICD-9 
code. An infection was considered serious when listed as a hospital admission 
diagnosis in the VHA inpatient setting. Our regression models controlled for 
patient demographic characteristics, comorbid conditions, drug exposures, 
disability status, and health care utilization. RESULTS: Our analysis cohort 
consisted of 7,743 MS and 30,972 non-MS patients. Mean age was 53.8 (SD 13.4) 
years and 80.7% were male. Race was known in 40.8%; of which 80.2% were 
white, 16.0% black, and 3.8% variant ethnicities. The incidence of overall serious 
infections was 18.7 (95% CI=17.2-20.3) and 10.0 (95% CI=9.5-10.6) per 1,000 
person-years for MS and non-MS patients, respectively. Regression models 
revealed that MS patients were at greater risk for overall serious infections 
(HR=1.54, p<0.001) as well as serious respiratory (HR=1.31, p=0.01), urinary tract 
